Does an IUD Cause Depression? The Evidence Explained

Hormonal IUDs are associated with a modest increase in depression diagnoses in large population studies, but the relationship is not straightforward enough to call it a clear cause. The biggest nationwide studies, tracking hundreds of thousands of women, consistently find that users of levonorgestrel-releasing IUDs (the hormonal type) are somewhat more likely to receive a depression diagnosis or start antidepressants than non-users. Yet the absolute risk remains low, the picture shifts dramatically depending on age and personal history, and some research points in the opposite direction entirely. The honest state of the science is more interesting than a simple yes or no.

What Nationwide Studies Actually Find

The strongest evidence on this question comes from Scandinavian registry studies, which can track entire populations over years using linked health and prescription databases. A Swedish register-based cohort study covering more than 700,000 women found that hormonal IUD use was associated with a 57% increased risk of depression compared to non-users. That sounds alarming as a percentage, but the absolute numbers tell a calmer story: the vast majority of hormonal IUD users in these studies never develop depression during follow-up.¹

A Danish nationwide cohort study followed over 46,000 first-time hormonal IUD users and observed 1,531 new cases of antidepressant initiation across roughly 80,000 person-years of follow-up. The standardized depression rate was about 31 per 1,000 person-years for the highest-dose device and about 18 per 1,000 person-years for the lowest-dose device.² To put those numbers in context, roughly 97 to 98 out of every 100 hormonal IUD users in the Danish study did not develop a new episode of depression in the first year.

These are observational studies, not randomized experiments, and researchers are careful to say they cannot prove the IUD caused the depression. Women who choose an IUD may differ in important ways from women who choose other methods or no contraception at all. But the consistency of the signal across large, well-designed studies makes it difficult to dismiss entirely.

The Dose-Dependent Pattern

One of the most compelling pieces of the puzzle is that the risk appears to scale with how much levonorgestrel the device releases. Hormonal IUDs currently come in several formulations containing different amounts of the synthetic progestin levonorgestrel: roughly 13.5 mg, 19.5 mg, and 52 mg total. The Danish study found that the adjusted one-year absolute risk of incident depression was about 1.2% for low-dose users, 1.5% for medium-dose users, and 1.8% for high-dose users. Compared to low-dose users, high-dose users had about a 52% higher risk of developing depression.³

This dose-response gradient matters because it is exactly what you would expect if levonorgestrel itself were driving the effect. Random confounders would not neatly line up by hormone dose. The researchers noted that while the observational design does not permit causal inference, the dose-response relationship strengthens the case that levonorgestrel exposure is meaningfully connected to depression risk.³ For women and their clinicians, this finding creates a practical option: choosing a lower-dose device might reduce the risk. In the Danish cohort, the low-dose devices were associated with roughly 11 to 13 fewer cases of depression per 1,000 person-years compared to the high-dose device.²

How Hormone From an IUD Reaches the Rest of the Body

A common misconception is that hormonal IUDs act only locally, delivering progestin to the uterus without any systemic effects. The device does concentrate its hormone locally: endometrial tissue sees levonorgestrel concentrations 200 to 800 times higher than what would result from taking a daily pill.⁴ But measurable amounts still enter the bloodstream. In users of the standard 52 mg device, plasma levonorgestrel levels average around 190 pg/mL in the first year and gradually decline to about 130 pg/mL by year three and beyond.⁵

These blood levels are lower than what you see with a levonorgestrel-containing pill or subdermal implant. Pharmacokinetic comparisons show the implant produces serum concentrations roughly 1.7 to 2.1 times higher than those of the highest-dose IUD, and the IUDs’ total bioavailability exceeds 97%.⁶ So while the hormonal IUD delivers less systemic progestin than most other hormonal methods, it is not zero. Body weight also plays a role: higher body mass is associated with lower plasma levels, which could mean the systemic effect varies from person to person.⁵

The Stress-Response Debate

If levonorgestrel from an IUD can affect mood, what mechanism might explain it? One line of research focuses on the body’s stress system. A laboratory study exposed women using levonorgestrel IUDs, women using combination oral contraceptives, and women using no hormonal method to a standardized psychological stress test. The IUD users showed a markedly exaggerated cortisol spike in response to the stressor and also had elevated hair cortisol, a marker of chronic stress exposure over months.⁷ The researchers described this as a central sensitization of the body’s stress axis, meaning the brain itself seemed to be dialing up the stress response.

However, a later prospective cohort study directly compared women who had just received a hormonal IUD with women who received a copper (non-hormonal) IUD. That study found no difference in hair cortisol concentrations between the two groups and reported favorable scores on mood questionnaires among hormonal IUD users.⁸ A separate study using structured stress induction in a lab setting found that IUD users reported higher negative feelings and more subjective stress and anxiety after stress exposure than women not using hormonal contraception, though their cortisol patterns were similar to non-users.⁹

The conflicting cortisol data is a good illustration of where the science stands right now: there are plausible biological pathways, but the evidence has not converged on a single clear mechanism. Another hypothesis involves neurosteroids, compounds the brain synthesizes from progesterone and related hormones that directly influence receptors involved in mood and anxiety regulation. Disruptions to these neurosteroid pathways have been linked to depression and anxiety in broader research, and introducing a synthetic progestin could theoretically interfere with this system.¹⁰ But that connection has not been directly demonstrated for IUD users.

Adolescents Face a Different Risk Profile

Age at insertion consistently emerges as one of the strongest modifiers of the depression signal. The Swedish study found that adolescents who received a hormonal IUD before age 20 had roughly two and a half times the risk of a depression diagnosis compared to women aged 20 to 24, with non-overlapping confidence intervals between the groups.¹¹ A separate analysis from the same register data noted that women using the hormonal IUD as their very first hormonal contraceptive method also had a higher risk, suggesting that hormonal naivety may amplify the vulnerability.¹

Whether adolescents are genuinely more biologically sensitive to levonorgestrel, or whether the higher numbers reflect that the teen years are already peak time for first episodes of depression, is an open question the data cannot fully resolve. The Swedish researchers acknowledged that confounding factors are likely contributing, pointing out that the overall risk estimates in their study decreased over the study period as the hormonal IUD became more widely accessible among younger, nulliparous women. That pattern suggests that at least some of the early signal was driven by the characteristics of who was getting the device, not just the device itself.¹ Still, the size of the difference is hard to ignore and is worth discussing with a clinician if you are a teenager or a parent of one considering this option.

The Postpartum Period Tells a Different Story

If you just had a baby and are weighing contraceptive options, the data looks surprisingly different. A systematic review of postpartum hormonal contraception and depression found that the single large study examining the hormonal IUD in the postpartum period actually showed a reduced risk of depression. Among over 3,000 postpartum IUD users in a military insurance database, the adjusted hazard ratio for a depression diagnosis was 0.65, meaning they were about 35% less likely to receive a depression diagnosis than postpartum women not using hormonal contraception.¹²

That finding goes against the general trend, and several explanations are possible. Postpartum hormone levels are in dramatic flux regardless of contraception, so the modest levonorgestrel from an IUD may not add a meaningful perturbation on top of what the body is already doing. Or the protection against unintended pregnancy, the reduced menstrual bleeding, and the convenience of a set-and-forget method may provide enough stress relief to offset any mood effect. One caveat: an analysis of the FDA’s adverse event reporting system flagged levonorgestrel (along with other hormonal contraceptives) as having an elevated reporting signal for postpartum depression.¹³ Adverse event databases capture self-reports and are heavily influenced by awareness and media coverage, so this signal is much weaker than registry evidence, but it means the question is not fully settled.

How Hormonal IUDs Compare to Other Methods

Putting the IUD in the context of other hormonal contraceptives helps frame the risk. A scoping review of psychiatric outcomes following hormonal contraception found that progestin-only methods (including pills, injectables like depot medroxyprogesterone acetate, and the levonorgestrel IUD) tended to carry larger effect sizes for depression than combined estrogen-progestin pills or the etonogestrel vaginal ring.¹⁴ This is broadly consistent with the pharmacokinetic data showing the subdermal implant produces even higher systemic levonorgestrel levels than the IUD.⁶

The relationship between progestogen type and mood appears to depend on which progestogen is used. Older oral contraceptive formulations containing certain progestins have been linked to more severe mood disturbances, while newer pills using different hormone types may be better tolerated. The amount and type of progestogen both seem to matter, not just whether a method is hormonal or not.¹⁵ This is good context for anyone being told “just switch to the pill” as a solution to mood concerns with an IUD: depending on which pill and which progestogen, you might be trading one risk profile for another.

Individual Vulnerability and the “Subset” Problem

Perhaps the most clinically relevant insight is that the general population finding may mask a subgroup that is genuinely sensitive. An overview of the literature on progesterone and psychiatric illness concluded that overall, the research does not support an association between exogenous progesterone-type hormones and negative mood in the general population, but does indicate that a subset of women may be vulnerable to such effects.¹⁶ In other words, most women tolerate these hormones without mood problems, but for a minority, the impact is real and can be significant.

Published case reports illustrate how dramatic the individual response can be. One woman developed a depressive syndrome with panic attacks within weeks of having a second levonorgestrel IUD inserted, despite having tolerated her first device well. After removal, her psychiatric symptoms resolved completely and remained absent at six- and twelve-month follow-up.¹⁷ Case reports cannot establish population-level risk, but they illustrate an important clinical reality: a device that was fine the first time around can trigger symptoms on re-insertion, and removal can resolve them.

Among adolescents already being treated for mental health conditions, one study found that depression symptoms reported by both hormonal IUD users and injectable contraceptive users were evaluated by mental health teams and attributed to pre-existing psychiatric conditions rather than the contraceptive method itself.¹⁸ Disentangling a pre-existing condition from a new drug effect is genuinely difficult, and clinicians sometimes default to assuming pre-existing illness is the sole driver. If your mood worsens shortly after getting an IUD and your clinician attributes it entirely to your prior history, it is reasonable to ask whether the timing suggests the device could be contributing.

The Nocebo Question and Copper IUD Claims

Whenever a contraceptive is widely discussed online as causing depression, the nocebo effect becomes part of the conversation. Research on oral contraceptive side effects has noted that when women are told to expect negative effects, those effects become more likely to occur through the power of suggestion, or they may simply reflect the background rate of mood symptoms in the general population.¹⁹ This does not mean the depression risk with hormonal IUDs is imaginary; the dose-response data argues against pure suggestion. But it does mean that individual reports (including your own perception) can be shaped by expectation, and that is worth being honest about.

As a counterpoint, even the copper IUD, which contains no hormones at all, has been the subject of online claims about depression, anxiety, and panic attacks. A qualitative study of healthcare communication found that some women attribute psychological symptoms to the copper released by non-hormonal devices, linking them to chronic inflammation.²⁰ The biological plausibility for this is far weaker than for levonorgestrel’s effects, but it is a useful reminder that inserting any foreign device into the uterus involves a physical and psychological adjustment period, and that attributing symptoms to whichever variable is most visible (the IUD) is human nature. The existence of mood complaints among copper IUD users makes the hormonal IUD data harder to interpret cleanly, but again, the dose-response pattern with levonorgestrel suggests the hormonal signal is not just noise.

Practical Steps If You Are Concerned

If you are considering a hormonal IUD and have a personal or family history of depression, the evidence does not say you must avoid one. Most women, even in the highest-risk subgroups studied, do not develop depression after insertion. But a few things are worth keeping in mind. Choosing a lower-dose device, where medically appropriate, is associated with a lower depression incidence in the Danish dose-comparison data.² Tracking your mood in the weeks after insertion can help separate a genuine worsening from the background fluctuations everyone experiences. And if you do develop new depressive symptoms, especially in the first few months, removal is straightforward and has been followed by rapid symptom resolution in documented cases.¹⁷

The trickiest part of this conversation is that levonorgestrel plasma levels decline over the life of the device, dropping from their peak in the first year to substantially lower levels by year three and beyond.⁵ If the hormone is the driver, mood effects should theoretically be greatest early on and fade with time. Some women who struggle initially may find that their symptoms settle without removal. Others may not want to wait that out, and that is a perfectly valid choice. The broader message from the research is not that hormonal IUDs are dangerous, but that they are not mood-neutral for everyone, and the evidence is finally becoming detailed enough to have a real conversation about who is most likely to notice the difference.